Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2018 Publisher: Wockhardt UK Ltd, Ash Road North, Wrexham, LL13 9UF, UK
Ceftriaxone 1g Powder for solution for injection.
| Pharmaceutical Form |
|---|
|
Powder for solution for injection (Powder for injection). White to pale yellow crystalline powder. |
Each vial contains ceftriaxone sodium equivalent to 1g of ceftriaxone.
Excipient with known effect: Each gram of ceftriaxone contains approximately 82 mg (3.6mmol) of sodium.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Ceftriaxone |
Ceftriaxone is an antibacterial for systemic use, a third-generation cephalosporin. It inhibits bacterial cell wall synthesis following attachment to penicillin binding proteins (PBPs) leading to bacterial cell lysis and death. |
| List of Excipients |
|---|
|
None. |
Ceftriaxone is supplied in Type II 15ml clear glass vials, closed with a Type I rubber stopper uncoated/coated in Omniflex and sealed with an aluminium/plastic cap.
The vials are packed in boxes of 1, 5, 10, 25 or 50 vials.
Not all pack sizes may be marketed.
Wockhardt UK Ltd, Ash Road North, Wrexham, LL13 9UF, UK
PL 29831/0034
Date of first authorisation: 16 October 2007
| Drug | Countries | |
|---|---|---|
| CEFTRIAXONE | Nigeria |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
